Pharmanutra SpA

Lobbying Governance

AI Extracted Evidence Snippet Source

In line with the Sustainability Plan (the "Plan") approved in 2023, the following actions were implemented: 1. With a view to sustainability, expansion of the functions of the Audit and Risk Committee, which has become the Audit, Risk and Sustainability Committee. In addition to supporting the Board of Directors' assessments and decisions on the internal control and risk management system, such Committee has proposal and advisory functions vis-à-vis the Board of Directors on sustainability issues such as: - examining and evaluating sustainability issues related to business operations and the dynamics of interaction with stakeholders; - examining and evaluating the system for collecting and consolidating data for the preparation of sustainability reports and documents that will be required in the future as a result of the European Union's sustainability regulations; - examining the Sustainability Report in advance, formulating an opinion for approval by the Board of Directors; - monitoring the Group's positioning on sustainability issues, with particular reference to the Group's ranking in ethical sustainability indices; - expressing opinions on any further sustainability issues at the request of the Board of Directors. 2. Assignment to an Executive Director of specific delegated powers for the management of the organisation's impacts on economy, the environment and people, and in particular: - proposing, coordinating and starting projects and initiatives in the area of social responsibility; - monitoring action plans for the implementation of the Sustainability Plan, also in the light of external best practices; - reviewing stakeholders' information and requests on sustainability issues and coordinating the drafting of the annual Sustainability Report. 3. Appointment of the Group's ESG Manager with the task of implementing the software for drafting the Sustainability Report, monitoring the KPIs defined in the Sustainability Plan and coordinating the operations team for the implementation of the operational actions envisaged in the plan and the reporting of results, contributing to the dissemination of the sustainability culture. For further details, please refer to the documents in the Governance section published on PharmaNutra Group's website.

https://www.pharmanutra.it/wp-content/uploads/2024/07/Pharmanutra-Group-Sustainability-Report-2023.pdf